6.
Singh S, Dammeijer F, Hendriks R
. Role of Bruton's tyrosine kinase in B cells and malignancies. Mol Cancer. 2018; 17(1):57.
PMC: 5817726.
DOI: 10.1186/s12943-018-0779-z.
View
7.
Lyzwa E, Sobiecka M, Lewandowska K, Siemion-Szczesniak I, Baranska I, Klatt M
. Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab-Challenging Recognition and Treatment. Viruses. 2023; 15(3).
PMC: 10051526.
DOI: 10.3390/v15030693.
View
8.
Moutinho-Pereira S, Calisto R, Sabio F, Guerreiro L
. High-titre convalescent plasma therapy for an immunocompromised patient with systemic lupus erythematosus with protracted SARS-CoV-2 infection. BMJ Case Rep. 2021; 14(8).
PMC: 8388267.
DOI: 10.1136/bcr-2021-244853.
View
9.
He X, Lau E, Wu P, Deng X, Wang J, Hao X
. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020; 26(5):672-675.
DOI: 10.1038/s41591-020-0869-5.
View
10.
Hettle D, Hutchings S, Muir P, Moran E
. Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: Retrospective cohort study and literature review. Clin Infect Pract. 2022; 16:100210.
PMC: 9666269.
DOI: 10.1016/j.clinpr.2022.100210.
View
11.
Gagelmann N, Passamonti F, Wolschke C, Massoud R, Niederwieser C, Adjalle R
. Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis. Haematologica. 2021; 107(8):1840-1849.
PMC: 9335098.
DOI: 10.3324/haematol.2021.280163.
View
12.
Machkovech H, Hahn A, Garonzik Wang J, Grubaugh N, Halfmann P, Johnson M
. Persistent SARS-CoV-2 infection: significance and implications. Lancet Infect Dis. 2024; 24(7):e453-e462.
DOI: 10.1016/S1473-3099(23)00815-0.
View
13.
Pan F, Ye T, Sun P, Gui S, Liang B, Li L
. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 2020; 295(3):715-721.
PMC: 7233367.
DOI: 10.1148/radiol.2020200370.
View
14.
Shoji K, Suzuki A, Okamoto M, Kagning Tsinda E, Sugawara N, Sasaki M
. Prolonged shedding of infectious viruses with haplotype switches of SARS-CoV-2 in an immunocompromised patient. J Infect Chemother. 2022; 28(7):1001-1004.
PMC: 8986523.
DOI: 10.1016/j.jiac.2022.04.004.
View
15.
Villasenor-Echavarri R, Gomez-Romero L, Martin-Onraet A, Herrera L, Escobar-Arrazola M, Ramirez-Vega O
. SARS-CoV-2 Genome Variations in Viral Shedding of an Immunocompromised Patient with Non-Hodgkin's Lymphoma. Viruses. 2023; 15(2).
PMC: 9962578.
DOI: 10.3390/v15020377.
View
16.
Nagai H, Saito M, Adachi E, Sakai-Tagawa Y, Yamayoshi S, Kiso M
. Casirivimab/Imdevimab for Active COVID-19 Pneumonia Which Persisted for Nine Months in a Patient with Follicular Lymphoma during Anti-CD20 Therapy. Jpn J Infect Dis. 2022; 75(6):608-611.
DOI: 10.7883/yoken.JJID.2022.092.
View
17.
Nagasaki Y, Kadowaki M, Nakamura A, Etoh Y, Shimo M, Ishihara S
. A Case of a Malignant Lymphoma Patient Persistently Infected with SARS-CoV-2 for More than 6 Months. Medicina (Kaunas). 2023; 59(1).
PMC: 9864643.
DOI: 10.3390/medicina59010108.
View
18.
Simpson S, Kay F, Abbara S, Bhalla S, Chung J, Chung M
. Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA - Secondary Publication. J Thorac Imaging. 2020; 35(4):219-227.
PMC: 7255403.
DOI: 10.1097/RTI.0000000000000524.
View
19.
Daoussis D, Leonidou L, Kalogeropoulou C, Paliogianni F, Tzouvelekis A
. Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed. Rheumatol Int. 2021; 41(10):1839-1843.
PMC: 8373601.
DOI: 10.1007/s00296-021-04969-2.
View
20.
Degli Antoni M, Crosato V, Pennati F, Borghesi A, Cristini G, Allegri R
. COVID-19 Pneumonia with Migratory Pattern in Agammaglobulinemic Patients: A Report of Two Cases and Review of Literature. Tomography. 2023; 9(3):894-900.
PMC: 10204514.
DOI: 10.3390/tomography9030073.
View